Some fresh ideas we’ve been working on...
Difficult Resupply
Expectations are at the heart of disappointment. Case in point, uranium and rubber gloves.
The Covid 72: 72 Stocks to Buy Now?
Sometimes Wikipedia really does capture the firefly of common wisdom. Take its explanation of the board game Risk: "A strategy game of diplomacy, conflict and conquest"...
Reading the Book of Covid
t’s a war-movie classic, perfect for a rainy day: George C. Scott, as U.S. World War II general George S. Patton, gloating as his forces rout the German tanks and troops under the command of Irwin Rommel.
The Case for Chubb
For those about to insure, we salute you. Particularly, Zurich-based insurance giant Chubb (CB).
On Winning the COVID Wars
As it has done countless times before, society has begun the deep restructuring needed to battle a serious invader. This time the enemy is called COVID-19.
The Case for Siemens (NBB)
It’s romantic to think glitzy delivery systems win wars. The fighters. The bombers. The bullets. The submarines. That’s where the crash and boom can be heard. But real victory comes from the boring hum of manufacturers making things that win battles.
Bye Bye Now: Google Eats Expedia (EXPE)
Travel is not a well understood market. But to us, Expedia (EXPE) has the most questions to answer. Yes, this is a $11.3 billion business with 80% gross margins, and a cool $1.9 billion in annual net cash flows from operations.
And They're Off: New Legalized Sports Betting Faces Dim Odds
William Hill, DraftKings, FanDuel, and the other online bookies know how to annoy.
The Name Is Bond: U.S. Treasury Bond
What is it about who plays James Bond that makes for such big news on trading desks around the world? Late this summer, we all learned that it would not be Sandra Oh, Idris Elba, Henry Cavill or any of the other wannabe Bonds.
Workhorse Group's (WKHS) Wild Ride in the Electric Commercial Truck Derby
LORDSTOWN, Ohio: The road to electric commercial vehicles usually leads to interesting places.
Starting the Drive Against Carvana (CVNA)
What makes this bumpy, early-2019 equity market so interesting is the smell of burnt investor coffee in the room.
Research In Positive Motion: The Compelling New Argument for Blackberry (BB)
Is it just us, or have you developed the same strange rituals we have after all these years of perceiving value out of the fog of investor gloom?
Direct-To-Consumer Genetic Testing Is Dead On (Investor) Arrival
Sometimes simply throwing in the towel is the right investor story to tell. And for this holiday season, the singular wasted business opportunity has got to be direct-to-consumer, or DTC, genetic testing.
The Shame Short: Betting against The New York Times (NYT) and "New Fox"
The year 2018 has been a bumper year for shame and humiliation, hasn’t it? But it won’t last, because ... it never does.
The Cheddar Effect: Business News Without All the Pesky Businesses.
Business news is about to become a semi-oxymoron.
The Coming Annuity Squeeze: Genworth Financial (GNW)
It's not like we get to write this sentence every day: There appears to be fresh, new value in the dusty old world of annuities.
With the Apocalypse Coming ...
With markets now in full new-school turmoil, so begins the search for old-school value. And how far wrong can any of us go, in these times of markets that go thump in the night, by looking at bugs?
A New Glow to Nuclear
One of the up sides of a down market is that -- strictly speaking on a legit risk-adjusted basis -- scary times are the time for scary bets.
Musk Shocks Tesla's Valuation.
Isn't it finally refreshing to see this in black and white: Tesla Inc. would be a far better company if Elon Musk no longer ran it.
The Intelligent AI Short: MasterCard.
We heard a good one from a smart young computer-engineer friend of ours, the other day. “If I ever randomly mess with the inputs to one my programs, I'd get fired that day.